Rational development of topical climbazole formulations

Area of Science:

• Dermatology and Pharmaceutical Sciences
• Cosmetic Science
• Drug Delivery Systems

Background:

• Dandruff (pityriasis capitis simplex) involves scalp flaking, scaling, and impaired barrier function.
• Climbazole (CBZ) is an antifungal agent used for dandruff management.
• Previous research characterized CBZ and its skin permeation from neat solvents.

Purpose of the Study:

• To evaluate in vitro human skin permeation of CBZ from complex formulations.
• To assess the influence of various solvent systems on CBZ skin uptake and penetration.
• To determine skin retention and permeation of individual solvents within the formulations.

Main Methods:

• In vitro permeation studies using human skin.
• Formulations included propylene glycol (PG), Transcutol®P (TC), octyl salicylate (OSal), and isopropyl alcohol (IPA).
• Development and validation of new analytical methods for PG, TC, and OSal quantification in skin.

Main Results:

• All tested vehicles promoted CBZ skin permeation.
• Binary (PG:TC, TC:OSal) and ternary (PG:IPA:OSal) vehicles showed no significant differences in CBZ permeation.
• Binary vehicles generally enhanced CBZ skin uptake compared to neat solvents; PG content influenced CBZ permeation in PG:TC and PG:IPA:OSal systems.
• TC permeated skin more readily than PG in binary systems.
• OSal content did not significantly affect CBZ uptake or permeation.

Conclusions:

• Complex formulations enhance climbazole (CBZ) skin permeation for dandruff treatment.
• Formulation composition significantly impacts CBZ skin delivery, and effects cannot be universally predicted.
• Understanding solvent effects is crucial for optimizing topical antifungal formulations.